Create Account | Sign In: Author or Forum

 
News  |  Journals  |  Conferences  |  Opinion  |  Articles  |  Forums  |  Twitter    
 
Category: Family Medicine | Gastroenterology | Internal Medicine | Journal

Back to Journal Articles

Treatment May Be Helpful at Various Stages of Cirrhosis

Last Updated: April 08, 2009.

 

Study examined responses to ursodeoxycholic acid in patients with primary biliary cirrhosis

Share |

Comments: (0)

Tell-a-Friend

 

  Related
 
Patients with primary biliary cirrhosis may have a better long-term outlook if ursodeoxycholic acid treatment normalizes their abnormal bilirubin or albumin concentrations, according to research published in the April issue of Gastroenterology.

WEDNESDAY, April 8 (HealthDay News) -- Patients with primary biliary cirrhosis may have a better long-term outlook if ursodeoxycholic acid (UDCA) treatment normalizes their abnormal bilirubin or albumin concentrations, according to research published in the April issue of Gastroenterology.

Edith M.M. Kuiper, of the Erasmus University Medical Center in Rotterdam, the Netherlands, and colleagues analyzed data from 375 patients with primary biliary cirrhosis who were followed for a median 9.7 years.

Those who responded to the treatment according to criteria proposed by Corpechot (based on alkaline phosphatase, aspartate aminotransferase, and bilirubin levels) and the Rotterdam group (based on normalization of abnormal bilirubin and/or albumin levels) had better survival than non-responders. The prognosis in early disease was similar for responders and non-responders, but in those with moderately advanced disease, responders had a better prognosis, the investigators found.

"In conclusion, the prognosis for the majority of patients with primary biliary cirrhosis (i.e., those presenting with early disease) is excellent and comparable with that of the general population when treatment with UDCA is instituted," the authors write. "Our study suggests that prognosis based on albumin and bilirubin levels is more accurate than prognosis based on changes in alkaline phosphatase level. Normalization of abnormal albumin and bilirubin concentrations following UDCA treatment is associated with improved prognosis. Therefore, our data are compatible with a therapeutic effect of UDCA in primary biliary cirrhosis, irrespective of the stage of the disease."

Two co-authors received a research grant from Zambon Nederland.

Abstract
Full Text (subscription or payment may be required)

Copyright © 2009 ScoutNews, LLC. All rights reserved.


Previous: Lifestyle Changes Key to Cutting Colorectal Cancer in UK Next: Two Industrial Chemicals Not Implicated in Risk of Cancers

Reader comments on this article are listed below. Review our comments policy.


Submit your opinion:

Name:

Email:

Location:

URL:

Remember my personal information

Notify me of follow-up comments?

advertisement.gif (61x7 -- 0 bytes)
 

Are you a Doctor, Pharmacist, PA or a Nurse?

Join the Doctors Lounge online medical community

  • Editorial activities: Publish, peer review, edit online articles.

Doctors Lounge Membership Application

 
     

 advertisement.gif (61x7 -- 0 bytes)

 

 

Useful Sites
MediLexicon
  Tools & Services: Follow DoctorsLounge on Twitter Follow us on Twitter | RSS News | Newsletter | Contact us
Copyright © 2001-2014
Doctors Lounge.
All rights reserved.

Medical Reference:
Diseases | Symptoms
Drugs | Labs | Procedures
Software | Tutorials

Advertising
Links | Humor
Forum Archive
CME | Conferences

Privacy Statement
Terms & Conditions
Editorial Board
About us | Email

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.